Abstract
Major advances in cancer therapy are attributable to clinical trials. There are two types of clinical trials: prospective and nonprospective trials. In prospective trials, subjects are allocated to two or more groups. One group serves as a “control” and receives whatever therapy is considered to be “standard” for the disease being studied. Standard therapy may be treatment with one or more drugs or, alternatively, no treatment. For example, the therapy given to patients in the control group of a clinical trial testing new treatments for metastatic carcinoma of the colon (colon cancer that has spread to distant organs) consists of the drug 5-fluorouracil. In contrast, standard therapy for the control group of patients with carcinoma of the colon that has not spread to distant organs is observation with no drug treatment. The other group(s) in the trial receive(s) the treatment(s) being tested. These may be a novel dose schedule of drugs known to have some effectiveness against the cancer being studied or a new drug not previously tested in the particular cancer.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Reference Notes
United States vs. Brandt, 2 Trials of War Criminals Before the Nuremberg Military Tribunals (The Medical Case), pp. 181-182, Military Tribunal I, 1947.
45 CFR Part 46, Section 46.111(a)(1)(i), Federal Register January 26, 1981; and Part 56, Section 56.111(a)(1)(i), Federal Register January 27, 1981.
Federal Register preamble to HHS final regulations, January 26, 1981, p. 8377; and Federal Register preamble to FDA final regulations, January 27, 1981, p. 8967.
45 CFR, Part 46, Section 46.111(a)(2), Federal Register January 26, 1981; and Part 56, Section 56.111(a)(2), Federal Register January 27, 1981.
45 CFR, Part 46, Section 46.116, Federal Register January 26, 1981.
45 CFR, Part 46, Section 46.116(b)(1)–(6), Federal Register January 26, 1981.
Research involving children, in: The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, pp. 4-5, DHEW Publication No. (OS) 77-0004, Washington, D.C., 1977.
43 CFR, 31793, Section 46.404(a)(6) Federal Register 1978.
DHEW Secretary’s Task Force on the Compensation of Injured Research Subjects, 1977, DHEW Publication No. (OS) 77-003, Washington, D.C.
43 CFR, 51.559, Federal Register, 1978.
Section 46.116(a)(6), Federal Register January 26, 1981, and Section 50.25(a)(6), Federal Register January 27, 1981.
References
Levine, R. J., and Lebacqz, K., 1979, Some ethical considerations in clinical trials, Clin. Pharm. Ther. 25:728–741.
Beauchamp, T. L. and Childress, J. F., 1979, Principles of Biomedical Ethics, Oxford University Press, New York.
WMA, 1964, Human experimentation: Code of ethics of the World Medical Association, Declaration of Helsinki, Brit. Med. J. 2:177.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Cowan, D.H. (1982). Research on the Therapy of Cancer. In: Greenwald, R.A., Ryan, M.K., Mulvihill, J.E. (eds) Human Subjects Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4157-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4157-4_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4159-8
Online ISBN: 978-1-4684-4157-4
eBook Packages: Springer Book Archive